<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2015-12-03" updated="2020-01-02">
  <drugbank-id primary="true">DB11081</drugbank-id>
  <name>Aluminum chloride</name>
  <description>Aluminum chloride is a chemical compound with the chemical formula AlCl3. When contaminated with iron chloride, it often displays a yellow color compared to the white pure compound. It is used in various chemical applications as a Lewis base, with anhydrous aluminium trichloride being the most commonly used Lewis acid. It may also be found in over-the-counter as an antiperspirant or prescription products as an antihemorrhagic agent. In antiperspirant products, FDA approves the use of aluminum chloride as an active ingredient up to 15%, calculated on the hexahydrate form, in an aqueous solution nonaerosol dosage form [L2012].</description>
  <cas-number>7446-70-0</cas-number>
  <unii>LIF1N9568Y</unii>
  <average-mass>133.341</average-mass>
  <monoisotopic-mass>131.888096562</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>investigational</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A32365</ref-id>
        <pubmed-id>25225553</pubmed-id>
        <citation>Tarighi P, Khoroushi M: A review on common chemical hemostatic agents in restorative dentistry. Dent Res J (Isfahan). 2014 Jul;11(4):423-8.</citation>
      </article>
      <article>
        <ref-id>A32367</ref-id>
        <pubmed-id/>
        <citation>Gupta S, Waters D,  Gwilt P: Absorption and disposition of aluminum in the rat Journal of Pharmaceutical Sciences. 1986 June 1;75(6):586-589.</citation>
      </article>
      <article>
        <ref-id>A32368</ref-id>
        <pubmed-id>24250398</pubmed-id>
        <citation>Khademi Kalantari K, Zeinalzade A, Kobarfard F, Nazary Moghadam S: The effect and persistency of 1% aluminum chloride hexahydrate iontophoresis in the treatment of primary palmar hyperhidrosis. Iran J Pharm Res. 2011 Summer;10(3):641-5.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <ref-id>L2012</ref-id>
        <title>FDA CFR - Code of Federal Regulations Title 21, PART 350: ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE</title>
        <url>https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=350&amp;showFR=1</url>
      </link>
      <link>
        <ref-id>L2013</ref-id>
        <title>ALUMINUM CHLORIDE - National Library of Medicine HSDB ... - Toxnet</title>
        <url>https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+607</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>- Indicated for the control of minor hemorrhage during dental restorative procedures.&#13;
- Indicated to reduce underarm perspiration.</indication>
  <pharmacodynamics>Aluminum chloride is a hemostatic and antiperspirant agent.</pharmacodynamics>
  <mechanism-of-action>Aluminum chloride is commonly used topical antiperspirant. It is proposed that aluminum chloride works by causing an obstruction of the distal sweat gland ducts, where the metal ions precipitate with mucopolysaccharides, damaging epithelial cells along the lumen of the duct and forming a plug that blocks sweat output [A32368]. Aluminum chloride is also an astringent that promotes hemostasis; it precipitates proteins on the superficial layer of mucosa and make it mechanically stronger [A32365]. It creates superficial and local coagulation in minor hemorrhages. </mechanism-of-action>
  <toxicity>Oral LD50 is 3470 mg/kg in rat and dermal LD50 is &gt; 2 g/kg in rabbit [MSDS]. As aluminum accumulates in the brain, ataxia and seizures may be observed following ingestion of higher doses. Mental status changes, including obtundation, lethargy and confusion may be seen [L2013]. Liver damage has been reported in acute and chronic toxicity of aluminum [L2013].</toxicity>
  <metabolism>In the small intestine, aluminum chloride is rapidly converted to insoluble poorly absorbed basic aluminum salts, consisting of a mixture of hydrated aluminum oxide, oxyaluminum hydroxide, various basic aluminum carbonates, and aluminum soaps [L2013]. </metabolism>
  <absorption>It is reported that about 17-30 % of aluminum chloride formed from the reaction between orally ingested aluminum hydroxide and hydrochloric acid of the stomach is absorbed [L2013]. In rabbits, administration of a single maximum safe oral dose aluminum chloride (333 mg Al/kg) resulted in aluminum absorption of 0.57 % [L2013]. Aluminum chloride may be absorbed via dermal route, with the uptake increasing in the microgram range but with an upper limit [L2013].</absorption>
  <half-life>Following oral administration of 8.1 mg/kg of aluminum chloride, the half-life of aluminum was 5.29 ± 0.47 h [A32367].</half-life>
  <protein-binding>Following oral administration of 8.1 mg/kg of aluminum chloride, the fraction of plasma protein binding of aluminum was approximately 98 % [A32367].</protein-binding>
  <route-of-elimination>Absorbed aluminum chloride is rapidly excreted by the kidneys in individuals with normal renal function [L2013]. Aluminum chloride may be absorbed dermally. </route-of-elimination>
  <volume-of-distribution>Following oral administration of 8.1 mg/kg of aluminum chloride, the steady‐state volume of distribution of aluminum was 38.4 ± 6.4 mL/kg [A32367].</volume-of-distribution>
  <clearance>Following oral administration of 8.1 mg/kg of aluminum chloride, the clearance of aluminum was 8.87 ± 1.76 mL/(h*kg) [A32367].</clearance>
  <classification>
    <description>This compound belongs to the class of inorganic compounds known as post-transition metal chlorides. These are inorganic compounds in which the largest halogen atom is Chlorine, and the heaviest metal atom is a post-transition metal.</description>
    <direct-parent>Post-transition metal chlorides</direct-parent>
    <kingdom>Inorganic compounds</kingdom>
    <superclass>Mixed metal/non-metal compounds</superclass>
    <class>Post-transition metal salts</class>
    <subclass>Post-transition metal chlorides</subclass>
    <alternative-parent>Inorganic chloride salts</alternative-parent>
    <substituent>Inorganic chloride salt</substituent>
    <substituent>Inorganic salt</substituent>
    <substituent>Post-transition metal chloride</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT001526</drugbank-id>
      <name>Aluminium chloride hexahydrate</name>
      <unii>3CYT62D3GA</unii>
      <cas-number>7784-13-6</cas-number>
      <inchikey>JGDITNMASUZKPW-UHFFFAOYSA-K</inchikey>
      <average-mass>241.432</average-mass>
      <monoisotopic-mass>239.951484678</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="english" coder="inn">Aluminium chloride</synonym>
  </synonyms>
  <products>
    <product>
      <name>Aarica</name>
      <labeller>The Podiatree Company</labeller>
      <ndc-id/>
      <ndc-product-code>54633-101</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-05-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>15 g/100mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aarica</name>
      <labeller>The Podiatree Company</labeller>
      <ndc-id/>
      <ndc-product-code>54633-413</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-05-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>15 g/100mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Anti-perspirant Roll-ON Deod</name>
      <labeller>Estee Lauder Dist</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00705268</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Antiperspirant Towlette</name>
      <labeller>Zero Sweat</labeller>
      <ndc-id/>
      <ndc-product-code>55726-200</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cloth</dosage-form>
      <strength>14 g/100g</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aquastop Liq</name>
      <labeller>Aqua Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00399868</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>2002-08-15</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Arrid Cream</name>
      <labeller>Carter Products, Division Of Carter Wallace Ns Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00493309</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1939-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-27</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>CERTAIN DRI Roll-On</name>
      <labeller>Dse Healthcare Solutions, Llc.</labeller>
      <ndc-id/>
      <ndc-product-code>89411-1140</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-05-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>12 mL/100mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CERTAIN DRI Roll-On</name>
      <labeller>Dse Healthcare Solutions, Llc.</labeller>
      <ndc-id/>
      <ndc-product-code>89411-1150</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>12 mg/1mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Certain Dri Roll-ON</name>
      <labeller>Clarion Brands, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69693-715</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>0.12 mg/1.0mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Certain Dri Roll-ON</name>
      <labeller>Denison Pharmaceuticals, Llc.</labeller>
      <ndc-id/>
      <ndc-product-code>0295-0122</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>0.12 mg/1.0mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinical Strength MiracleDry Antiperspirant Deodorant PM</name>
      <labeller>Highland Consumer Products</labeller>
      <ndc-id/>
      <ndc-product-code>53897-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-10-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>12 mg/1mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Denti-care Hemostatic Solution</name>
      <labeller>Amd Medicom Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239706</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-11-26</started-marketing-on>
      <ended-marketing-on>2006-08-03</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Dr Sweat</name>
      <labeller>Conopco Inc. d/b/a/ Unilever</labeller>
      <ndc-id/>
      <ndc-product-code>64942-1633</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>15 g/100g</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Duradry PM</name>
      <labeller>Novadore USA, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>69990-100</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Gel</dosage-form>
      <strength>150 mg/1mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Frenna AC</name>
      <labeller>Dharma Research, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>53045-300</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>8.75 g/35g</strength>
      <route>Dental; Oral; Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gibson Healthcare Buffered Hemostatic Solution</name>
      <labeller>Benco Dental</labeller>
      <ndc-id/>
      <ndc-product-code>66975-359</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>7500 mg/30mL</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gingi Aid 10%</name>
      <labeller>Gingi Pak Labs, Division Of Belport Co., Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00479357</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gingi Aid 25%</name>
      <labeller>Gingi Pak Labs, Division Of Belport Co., Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00479365</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2004-08-16</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gingi Aid Dark Braid #2</name>
      <labeller>Gingi Pak Labs, Division Of Belport Co., Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00539341</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-11</ended-marketing-on>
      <dosage-form>Packing</dosage-form>
      <strength/>
      <route>Dental; Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gingi Aid Dark Braid #3</name>
      <labeller>Gingi Pak Labs, Division Of Belport Co., Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00479381</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-11</ended-marketing-on>
      <dosage-form>Packing</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gingi-Aid Solution</name>
      <labeller>Gingi-Pak a Division of the Belport</labeller>
      <ndc-id/>
      <ndc-product-code>10129-017</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-04-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>3.75 g/15mL</strength>
      <route>Dental; Oral; Periodontal</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gingigel Gel 200mg/gm</name>
      <labeller>Van R Dental Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00687588</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2007-07-31</ended-marketing-on>
      <dosage-form>Gel</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemal</name>
      <labeller>Darby Dental Supply Llc</labeller>
      <ndc-id/>
      <ndc-product-code>66467-1081</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1963-02-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>250 mg/1g</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hemoban</name>
      <labeller>Dentsply Llc, Professional Division, Trading As "Sultan Healthcare"</labeller>
      <ndc-id/>
      <ndc-product-code>0699-1081</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1963-02-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>250 mg/1g</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hemoban</name>
      <labeller>DSHealthcare</labeller>
      <ndc-id/>
      <ndc-product-code>0699-1082</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1963-02-19</started-marketing-on>
      <ended-marketing-on>2010-02-04</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>250 mg/1g</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hemogin L Hemostatic Liq 25%</name>
      <labeller>Van R Dental Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00572632</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2005-08-04</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemostat</name>
      <labeller>Cargus International, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>61509-100</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>7500 mg/30mL</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hemostat</name>
      <labeller>Pearson Dental Supplies INC.</labeller>
      <ndc-id/>
      <ndc-product-code>43305-0000</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-01-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>7500 mg/30mL</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hemostatic Solution</name>
      <labeller>Crosstex International Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>24794-300</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-01-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>7500 mg/30mL</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hemox A</name>
      <labeller>Mycone Dental Supply Co., Inc Dba Keystone Industries And Deepak Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68400-203</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-01-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>7500 mg/30mL</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hydrosal Professional</name>
      <labeller>Valeo Pharma Corp.</labeller>
      <ndc-id/>
      <ndc-product-code>30707-100</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-10-01</started-marketing-on>
      <ended-marketing-on>2017-12-31</ended-marketing-on>
      <dosage-form>Gel</dosage-form>
      <strength>15 g/100mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hypercare</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-0123</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-04-21</started-marketing-on>
      <ended-marketing-on>2013-01-15</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hypercare</name>
      <labeller>Stratus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58980-150</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-04-21</started-marketing-on>
      <ended-marketing-on>2015-04-09</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hypercare</name>
      <labeller>Stratus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58980-155</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-01-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>15 g/100mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Lumicain</name>
      <labeller>Medicap Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>10733-412</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>250 mg/1g</strength>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Mitchum Anti Perspirant Crm Scented</name>
      <labeller>Mitchum Thayer Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00365386</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1965-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Mitchum Antipersp Crm Unscented</name>
      <labeller>Mitchum Thayer Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00570885</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ms Hemostatic</name>
      <labeller>M&amp;S Dental Supply Co., Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69745-050</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-09-01</started-marketing-on>
      <ended-marketing-on>2019-03-21</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>7500 mg/30mL</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>NRG Hemo-Stat</name>
      <labeller>IQ Dental Supply, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>42756-1100</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>7500 mg/30mL</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Purax</name>
      <labeller>Purax International GmbH</labeller>
      <ndc-id/>
      <ndc-product-code>76118-0003</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-02-17</started-marketing-on>
      <ended-marketing-on>2023-12-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>15 mg/1mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Purax Pure Pads</name>
      <labeller>Purax International GmbH</labeller>
      <ndc-id/>
      <ndc-product-code>76118-0001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-03-28</started-marketing-on>
      <ended-marketing-on>2013-08-09</ended-marketing-on>
      <dosage-form>Aerosol, spray</dosage-form>
      <strength>150 mg/1mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Purax Pure Pads</name>
      <labeller>Purax International GmbH</labeller>
      <ndc-id/>
      <ndc-product-code>76118-0002</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-03-28</started-marketing-on>
      <ended-marketing-on>2013-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>150 mg/1mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Racestyptine Cord</name>
      <labeller>Septodont</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00379646</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2000-08-03</ended-marketing-on>
      <dosage-form>Packing</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Racestyptine Sol</name>
      <labeller>Septodont</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00379638</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>2017-07-07</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Scotts Select NEPHRO-stat</name>
      <labeller>Scott's Dental Supply, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69638-059</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>7500 mg/30mL</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sulpak II</name>
      <labeller>North Pacific Dental Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00609285</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>1997-12-22</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sweatblock</name>
      <labeller>DC Alpine Partners, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>54913-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-12-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>140 mg/1mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Topical Hemo-Stat</name>
      <labeller>Henry Schein</labeller>
      <ndc-id/>
      <ndc-product-code>0404-1080</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1963-02-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>250 mg/1g</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Xerac AC</name>
      <labeller>Person and Covey</labeller>
      <ndc-id/>
      <ndc-product-code>0096-0709</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>0.0625 g/1g</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Xeransis</name>
      <labeller>Xeransis Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69726-003</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-04-20</started-marketing-on>
      <ended-marketing-on>2016-12-31</ended-marketing-on>
      <dosage-form>Spray</dosage-form>
      <strength>5.325 g/35.5mL</strength>
      <route>Epidural</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Xeransis</name>
      <labeller>Xeransis Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69726-002</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-04-20</started-marketing-on>
      <ended-marketing-on>2015-04-13</ended-marketing-on>
      <dosage-form>Spray</dosage-form>
      <strength>4.4375 g/35.5mL</strength>
      <route>Epidural</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Youth Dew Roll On Antipersp Deod Lot</name>
      <labeller>Estee Lauder Dist</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00629065</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2000-07-25</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>ZeroSweat 3 DAY PROTECTION ANTIPERSPIRANT</name>
      <labeller>ZeroSweat Inc</labeller>
      <ndc-id/>
      <ndc-product-code>55726-048</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-06-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>15 mg/1mL</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ZeroSweat with Aloe</name>
      <labeller>I. Shay Cosmetics</labeller>
      <ndc-id/>
      <ndc-product-code>65112-259</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Lotion</dosage-form>
      <strength>0.12 g/1g</strength>
      <route>Topical</route>
      <fda-application-number>part350</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Topical Hemo-Stat</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Lumicain</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>CERTAIN DRI Roll-On</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hypercare</name>
      <ingredients>Aluminum chloride + Ethanol</ingredients>
    </mixture>
    <mixture>
      <name>Frenna AC</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Purax Pure Pads</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Purax Pure Pads</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aarica</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>CERTAIN DRI Roll-On</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemal</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hypercare</name>
      <ingredients>Aluminum chloride + Ethanol</ingredients>
    </mixture>
    <mixture>
      <name>ZeroSweat 3 DAY PROTECTION ANTIPERSPIRANT</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hydrosal Professional</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemoban</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hypercare</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemostatic Solution</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinical Strength MiracleDry Antiperspirant Deodorant PM</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aarica</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Certain Dri Roll-ON</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Xeransis</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Certain Dri Roll-ON</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemoban</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Xeransis</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Gingi-Aid Solution</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Gibson Healthcare Buffered Hemostatic Solution</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Purax</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Scotts Select NEPHRO-stat</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemox A</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemostat</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemostat</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Ms Hemostatic</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Dr Sweat</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Antiperspirant Towlette</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Xerac AC</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>ZeroSweat with Aloe</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>NRG Hemo-Stat</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Duradry PM</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Sweatblock</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aquastop Liq</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Gingi Aid 10%</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Gingi Aid 25%</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Mitchum Anti Perspirant Crm Scented</name>
      <ingredients>Alcloxa + Aluminum chloride + Aluminum chlorohydrate</ingredients>
    </mixture>
    <mixture>
      <name>Arrid Cream</name>
      <ingredients>Aluminum chloride + Aluminum chlorohydrate</ingredients>
    </mixture>
    <mixture>
      <name>Mitchum Antipersp Crm Unscented</name>
      <ingredients>Alcloxa + Aluminum chloride + Aluminum chlorohydrate</ingredients>
    </mixture>
    <mixture>
      <name>Youth Dew Roll On Antipersp Deod Lot</name>
      <ingredients>Aluminum chloride + Aluminum chlorohydrate</ingredients>
    </mixture>
    <mixture>
      <name>Racestyptine Cord</name>
      <ingredients>Aluminum chloride + Lidocaine + Oxyquinoline</ingredients>
    </mixture>
    <mixture>
      <name>Sulpak II</name>
      <ingredients>Aluminum chloride + Oxyquinoline</ingredients>
    </mixture>
    <mixture>
      <name>Hemogin L Hemostatic Liq 25%</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Gingi Aid Dark Braid #3</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Gingi Aid Dark Braid #2</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Denti-care Hemostatic Solution</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Gingigel Gel 200mg/gm</name>
      <ingredients>Aluminum chloride</ingredients>
    </mixture>
    <mixture>
      <name>Anti-perspirant Roll-ON Deod</name>
      <ingredients>Aluminum chloride + Aluminum chlorohydrate</ingredients>
    </mixture>
    <mixture>
      <name>Racestyptine Sol</name>
      <ingredients>Aluminum chloride + Oxyquinoline</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Acids</category>
      <mesh-id>D000143</mesh-id>
    </category>
    <category>
      <category>Acids, Noncarboxylic</category>
      <mesh-id>D000148</mesh-id>
    </category>
    <category>
      <category>Aluminium Compounds</category>
      <mesh-id>D017607</mesh-id>
    </category>
    <category>
      <category>Anions</category>
      <mesh-id>D000838</mesh-id>
    </category>
    <category>
      <category>Anti-Acne Preparations</category>
      <mesh-id/>
    </category>
    <category>
      <category>Anti-Acne Preparations for Topical Use</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antiperspirants</category>
      <mesh-id>D051520</mesh-id>
    </category>
    <category>
      <category>Astringents and Deodorants</category>
      <mesh-id/>
    </category>
    <category>
      <category>Chlorides</category>
      <mesh-id>D002712</mesh-id>
    </category>
    <category>
      <category>Chlorine Compounds</category>
      <mesh-id>D017606</mesh-id>
    </category>
    <category>
      <category>Compounds used in a research, industrial, or household setting</category>
      <mesh-id>D020313</mesh-id>
    </category>
    <category>
      <category>Cosmetics</category>
      <mesh-id>D003358</mesh-id>
    </category>
    <category>
      <category>Dental Agents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Dermatologicals</category>
      <mesh-id>D003879</mesh-id>
    </category>
    <category>
      <category>Electrolytes</category>
      <mesh-id>D004573</mesh-id>
    </category>
    <category>
      <category>Household Products</category>
      <mesh-id>D006795</mesh-id>
    </category>
    <category>
      <category>Ions</category>
      <mesh-id>D007477</mesh-id>
    </category>
    <category>
      <category>Metal cations</category>
      <mesh-id>D002412</mesh-id>
    </category>
    <category>
      <category>Metal divalent cations</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength>15 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Cloth</form>
      <route>Topical</route>
      <strength>14 g/100g</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength>0.12 mg/1.0mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength>12 mL/100mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength>12 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength>15 g/100g</strength>
    </dosage>
    <dosage>
      <form>Gel</form>
      <route>Topical</route>
      <strength>150 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Dental; Oral; Topical</route>
      <strength>8.75 g/35g</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Dental</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Packing</form>
      <route>Dental; Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Packing</form>
      <route>Dental</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Dental; Oral; Periodontal</route>
      <strength>3.75 g/15mL</strength>
    </dosage>
    <dosage>
      <form>Gel</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Dental</route>
      <strength>7500 mg/30mL</strength>
    </dosage>
    <dosage>
      <form>Gel</form>
      <route>Topical</route>
      <strength>15 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Topical</route>
      <strength>15 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Topical</route>
      <strength>250 mg/1g</strength>
    </dosage>
    <dosage>
      <form>Cream</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Aerosol, spray</form>
      <route>Topical</route>
      <strength>150 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength>150 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Packing</form>
      <route>Dental</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Dental</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Topical</route>
      <strength>140 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Dental</route>
      <strength>250 mg/1g</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength>0.0625 g/1g</strength>
    </dosage>
    <dosage>
      <form>Spray</form>
      <route>Epidural</route>
      <strength>4.4375 g/35.5mL</strength>
    </dosage>
    <dosage>
      <form>Spray</form>
      <route>Epidural</route>
      <strength>5.325 g/35.5mL</strength>
    </dosage>
    <dosage>
      <form>Lotion</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength>15 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Lotion</form>
      <route>Topical</route>
      <strength>0.12 g/1g</strength>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="D10AX01">
      <level code="D10AX">Other anti-acne preparations for topical use</level>
      <level code="D10A">ANTI-ACNE PREPARATIONS FOR TOPICAL USE</level>
      <level code="D10">ANTI-ACNE PREPARATIONS</level>
      <level code="D">DERMATOLOGICALS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>34:00.00</ahfs-code>
    <ahfs-code>84:12.00</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB11081.pdf?1522775608</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB01586</drugbank-id>
      <name>Ursodeoxycholic acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02123</drugbank-id>
      <name>Glycochenodeoxycholic Acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Glycochenodeoxycholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02659</drugbank-id>
      <name>Cholic Acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Cholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02691</drugbank-id>
      <name>Glycocholic acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Glycocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03619</drugbank-id>
      <name>Deoxycholic acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Deoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04348</drugbank-id>
      <name>Taurocholic acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Taurocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05990</drugbank-id>
      <name>Obeticholic acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06777</drugbank-id>
      <name>Chenodeoxycholic acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Chenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08833</drugbank-id>
      <name>Taurochenodeoxycholic acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Taurochenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08834</drugbank-id>
      <name>Tauroursodeoxycholic acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Tauroursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08857</drugbank-id>
      <name>Bamet-UD2</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Bamet-UD2 resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11622</drugbank-id>
      <name>Dehydrocholic acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Dehydrocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11789</drugbank-id>
      <name>Hyodeoxycholic Acid</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Hyodeoxycholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06210</drugbank-id>
      <name>Eltrombopag</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06817</drugbank-id>
      <name>Raltegravir</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08930</drugbank-id>
      <name>Dolutegravir</name>
      <description>The serum concentration of Dolutegravir can be decreased when it is combined with Aluminum chloride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01218</drugbank-id>
      <name>Halofantrine</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08858</drugbank-id>
      <name>cis-Diamminechlorocholylglycinateplatinum(II)</name>
      <description>The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Aluminum chloride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11860</drugbank-id>
      <name>Aramchol</name>
      <description>The serum concentration of Aramchol can be decreased when it is combined with Aluminum chloride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14016</drugbank-id>
      <name>Ox bile extract</name>
      <description>The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum chloride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09139</drugbank-id>
      <name>Technetium Tc-99m oxidronate</name>
      <description>The serum concentration of Technetium Tc-99m oxidronate can be increased when it is combined with Aluminum chloride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00252</drugbank-id>
      <name>Phenytoin</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00532</drugbank-id>
      <name>Mephenytoin</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Mephenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00564</drugbank-id>
      <name>Carbamazepine</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00849</drugbank-id>
      <name>Methylphenobarbital</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01174</drugbank-id>
      <name>Phenobarbital</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01609</drugbank-id>
      <name>Deferasirox</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01071</drugbank-id>
      <name>Mequitazine</name>
      <description>Aluminum chloride can cause a decrease in the absorption of Mequitazine resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>1.65</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>trichloroalumane</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>aluminium chloride</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>133.341</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>131.888096562</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>Cl[Al](Cl)Cl</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>AlCl3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/Al.3ClH/h;3*1H/q+3;;;/p-3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>VSCWAEJMTAWNJL-UHFFFAOYSA-K</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>18.41</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>9.49</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>Water reactive</value>
      <source>MSDS</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>194</value>
      <source>MSDS</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>5821</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>30114</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>24012</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347827889</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>22445</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Aluminum_chloride</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL3833401</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0000180</id>
      <name>Glutamate dehydrogenase 1, mitochondrial</name>
      <organism>Humans</organism>
      <actions>
        <action>inactivator</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A19884</ref-id>
            <pubmed-id>14625697</pubmed-id>
            <citation>Yang SJ, Huh JW, Lee JE, Choi SY, Kim TU, Cho SW: Inactivation of human glutamate dehydrogenase by aluminum. Cell Mol Life Sci. 2003 Nov;60(11):2538-46.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P00367" source="Swiss-Prot">
        <name>Glutamate dehydrogenase 1, mitochondrial</name>
        <general-function>Nad+ binding</general-function>
        <specific-function>Mitochondrial glutamate dehydrogenase that converts L-glutamate into alpha-ketoglutarate. Plays a key role in glutamine anaplerosis by producing alpha-ketoglutarate, an important intermediate in the tricarboxylic acid cycle. May be involved in learning and memory reactions by increasing the turnover of the excitatory neurotransmitter glutamate (By similarity).</specific-function>
        <gene-name>GLUD1</gene-name>
        <locus>10q23.3</locus>
        <cellular-location>Mitochondrion matrix</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.91</theoretical-pi>
        <molecular-weight>61397.315</molecular-weight>
        <chromosome-location>10</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4335</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GLUD1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X07674</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>31707</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P00367</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>DHE3_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.4.1.3</synonym>
          <synonym>GDH 1</synonym>
          <synonym>GLUD</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000359|Glutamate dehydrogenase 1, mitochondrial
MYRYLGEALLLSRAGPAALGSASADSAALLGWARGQPAAAPQPGLALAARRHYSEAVADR
EDDPNFFKMVEGFFDRGASIVEDKLVEDLRTRESEEQKRNRVRGILRIIKPCNHVLSLSF
PIRRDDGSWEVIEGYRAQHSQHRTPCKGGIRYSTDVSVDEVKALASLMTYKCAVVDVPFG
GAKAGVKINPKNYTDNELEKITRRFTMELAKKGFIGPGIDVPAPDMSTGEREMSWIADTY
ASTIGHYDINAHACVTGKPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFG
DKTFVVQGFGNVGLHSMRYLHRFGAKCIAVGESDGSIWNPDGIDPKELEDFKLQHGSILG
FPKAKPYEGSILEADCDILIPAASEKQLTKSNAPRVKAKIIAEGANGPTTPEADKIFLER
NIMVIPDLYLNAGGVTVSYFEWLKNLNHVSYGRLTFKYERDSNYHLLMSVQESLERKFGK
HGGTIPIVPTAEFQDRISGASEKDIVHSGLAYTMERSARQIMRTAMKYNLGLDLRTAAYV
NAIEKVFKVYNEAGVTFT</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010191|Glutamate dehydrogenase 1, mitochondrial (GLUD1)
ATGTACCGCTACCTGGGCGAAGCGCTGTTGCTGTCCCGGGCCGGGCCCGCTGCCCTGGGC
TCGGCGTCCGCCGACTCGGCCGCGTTGCTGGGCTGGGCCCGGGGACAGCCCGCCGCCGCC
CCGCAGCCGGGGCTGGCATTGGCCGCCCGGCGCCACTACAGCGAGGCGGTGGCCGACCGC
GAGGACGACCCCAACTTCTTCAAGATGGTGGAGGGCTTCTTCGATCGCGGCGCCAGCATC
GTGGAGGACAAGCTGGTGGAGGACCTGAGGACCCGGGAGAGCGAGGAGCAGAAGCGGAAC
CGGGTGCGCGGCATCCTGCGGATCATCAAGCCCTGCAACCATGTGCTGAGTCTCTCCTTC
CCCATCCGGCGCGACGACGGCTCCTGGGAGGTCATCGAAGGCTACCGGGCCCAGCACAGC
CAGCACCGCACGCCCTGCAAGGGAGGTATCCGTTACAGCACTGATGTGAGTGTAGATGAA
GTAAAAGCTTTGGCTTCTCTGATGACATACAAGTGTGCAGTGGTTGATGTGCCGTTTGGG
GGTGCTAAAGCTGGTGTTAAGATCAATCCCAAGAACTATACTGATAATGAATTGGAAAAG
ATCACAAGGAGGTTCACCATGGAGCTAGCAAAAAAGGGCTTTATTGGTCCTGGCATTGAT
GTGCCTGCTCCAGACATGAGCACAGGTGAGCGGGAGATGTCCTGGATCGCTGATACCTAT
GCCAGCACCATAGGGCACTATGATATTAATGCACACGCCTGTGTTACTGGTAAACCCATC
AGCCAAGGGGGAATCCATGGACGCATCTCTGCTACTGGCCGTGGTGTCTTCCATGGGATT
GAAAATTTCATCAATGAAGCTTCTTACATGAGCATTTTAGGAATGACACCAGGGTTTGGA
GATAAAACATTTGTTGTTCAGGGATTTGGTAATGTGGGCCTACACTCTATGAGATATTTA
CATCGTTTTGGTGCTAAATGTATTGCTGTTGGTGAGTCTGATGGGAGTATATGGAATCCA
GATGGTATTGACCCAAAGGAACTGGAAGACTTCAAATTGCAACATGGGTCCATTCTGGGC
TTCCCCAAGGCAAAGCCCTATGAAGGAAGCATCTTGGAGGCCGACTGTGACATACTGATC
CCAGCTGCCAGTGAGAAGCAGTTGACCAAATCCAACGCACCCAGAGTCAAAGCCAAGATC
ATTGCTGAAGGTGCCAATGGGCCAACAACTCCAGAAGCTGACAAGATCTTCCTGGAGAGA
AACATTATGGTTATTCCAGATCTCTACTTGAATGCTGGAGGAGTGACAGTATCTTACTTT
GAGTGGCTGAAGAATCTAAATCATGTCAGCTATGGCCGTTTGACCTTCAAATATGAAAGG
GATTCTAACTACCACTTGCTCATGTCTGTTCAAGAGAGTTTAGAAAGAAAATTTGGAAAG
CATGGTGGAACTATTCCCATTGTACCCACGGCAGAGTTCCAAGACAGGATATCGGGTGCA
TCTGAGAAAGACATCGTGCACTCTGGCTTGGCATACACAATGGAGCGTTCTGCCAGGCAA
ATTATGCGCACAGCCATGAAGTATAACCTGGGATTGGACCTGAGAACAGCTGCCTATGTT
AATGCCATTGAGAAAGTCTTCAAAGTGTACAATGAAGCTGGTGTGACCTTCACATAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00208</identifier>
            <name>ELFV_dehydrog</name>
          </pfam>
          <pfam>
            <identifier>PF02812</identifier>
            <name>ELFV_dehydrog_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ADP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glutamate dehydrogenase (NAD+) activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glutamate dehydrogenase [NAD(P)+] activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>GTP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>identical protein binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>leucine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>NAD+ binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular amino acid biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glutamate biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glutamate catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glutamine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of insulin secretion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>substantia nigra development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tricarboxylic acid metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>